PrEP (HIV Pre-Exposure Prophylaxis)

The Latest

In Georgia's Metropolitan Heart, HIV Beats On

Our new "Eyes on the End" series kicks off with an up-close-and-personal glimpse at what's driving the HIV epidemic in the Atlanta metropolitan area.

By Tim Murphy

Kamala Harris Announces New Bill to Expand PrEP Access

The PrEP Access and Coverage Act would guarantee insurance coverage for PrEP and fund PrEP for the uninsured.

By Mathew Rodriguez

Pressure Mounts on Truvada PrEP Pricing With Lawsuit and Congressional Hearings

"This isn't about you," Rep. Alexandria Ocasio-Cortez (D-NY) told Gilead CEO Daniel O'Day. "We have legislated a system that allows [this] to happen."

By Tim Murphy

Will Recent Gilead Patent Concessions on Truvada Lower PrEP Prices?

Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.

By Tim Murphy

Has Anyone Gotten HIV When They Were on PrEP?

One of the persisting fears people may have when starting PrEP is wondering whether a risk remains of contracting HIV while on PrEP without using an additional barrier method.

By Damon L. Jacobs, L.M.F.T.

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

The #PrEP4All campaign made the call for affordable pre-exposure prophylaxis a national news story.

By Charles Sanchez

If Nobody Slashes the Price of Truvada for PrEP, What Happens Next?

Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.

By Tim Murphy

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.

By Sony Salzman

Doctors Aren't Offering Young People PrEP. That Has to Change.

For LGBT Health Awareness Week, educator Tyunique Nelson argues that PrEP education and access for youth have to be a top priority.

By Tyunique Nelson

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.

By Sony Salzman